Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Cervical Cancer

  Free Subscription


03.06.2019

1 Am J Obstet Gynecol
2 Asian Pac J Cancer Prev
1 BJR Case Rep
1 BMC Cancer
2 BMC Infect Dis
1 Br J Radiol
2 Cancer Cell Int
1 Cancer Manag Res
1 Clin Obstet Gynecol
1 Colloids Surf B Biointerfaces
1 Cureus
1 Eur Radiol
1 Exp Cell Res
1 Front Oncol
2 Gynecol Minim Invasive Ther
1 Int J Cancer
2 Int J Clin Oncol
1 Int J Gynaecol Obstet
1 Int J Gynecol Cancer
2 Int J Radiat Oncol Biol Phys
1 J BUON
1 J Cell Physiol
1 J Contemp Brachytherapy
1 J Gynecol Oncol
1 J Health Care Poor Underserved
1 J Low Genit Tract Dis
1 J Med Econ
1 J Obstet Gynaecol Can
1 J Obstet Gynaecol Res
1 JAMA
2 Medicine (Baltimore)
1 Mol Med
1 Mol Med Rep
2 Obstet Gynecol
1 Obstet Gynecol Sci
1 PLoS One
1 Prev Med
1 Radiology
1 Redox Biol
1 Sci Rep
1 Support Care Cancer
1 Surg Case Rep
2 Taiwan J Obstet Gynecol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Obstet Gynecol

  1. PAPATLA K, Halpern MT, Hernandez E, Brown J, et al
    Second primary anal and oropharyngeal cancers in cervical cancer survivors.
    Am J Obstet Gynecol. 2019 May 22. pii: S0002-9378(19)30683.
    PubMed     Text format     Abstract available


    Asian Pac J Cancer Prev

  2. KHALKHALI HR, Gharaaghaji R, Valizadeh R, Kousehlou Z, et al
    Ten Years' Survival in Patients with Cervical Cancer and Related Factors in West Azerbaijan Province: Using of Cox Proportion Hazard Model
    Asian Pac J Cancer Prev. 2019;20:1345-1351.
    PubMed     Text format     Abstract available

  3. GRANADOS-GARCIA V, Pina-Sanchez P, Reynoso-Noveron N, Flores YN, et al
    Medical Cost to Treat Cervical Cancer Patients at a Social Security Third Level Oncology Hospital in Mexico City
    Asian Pac J Cancer Prev. 2019;20:1547-1554.
    PubMed     Text format     Abstract available


    BJR Case Rep

  4. WEBB K, Prakash V, Kirresh O, Stewart A, et al
    A case of aortitis during cisplatin-based chemotherapy for cervical cancer.
    BJR Case Rep. 2018;5:20180054.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. SONG Q, Yi F, Zhang Y, Jun Li DK, et al
    CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
    BMC Cancer. 2019;19:499.
    PubMed     Text format     Abstract available


    BMC Infect Dis

  6. SKOULAKIS A, Fountas S, Mantzana-Peteinelli M, Pantelidi K, et al
    Prevalence of human papillomavirus and subtype distribution in male partners of women with cervical intraepithelial neoplasia (CIN): a systematic review.
    BMC Infect Dis. 2019;19:192.
    PubMed     Text format     Abstract available

  7. KIWERSKA K, Jozefiak A, Markowska J, Kedzia W, et al
    Oral-genital human papillomavirus infection in Polish couples: frequent detection of HPV 42.
    BMC Infect Dis. 2019;19:122.
    PubMed     Text format     Abstract available


    Br J Radiol

  8. WHITE IM, Scurr E, Wetscherek A, Brown G, et al
    Realising the potential of magnetic resonance image guided radiotherapy in gynaecological and rectal cancer.
    Br J Radiol. 2019 Apr 1:20180670. doi: 10.1259/bjr.20180670.
    PubMed     Text format     Abstract available


    Cancer Cell Int

  9. MIAO H, Wang N, Shi LX, Wang Z, et al
    Overexpression of mircoRNA-137 inhibits cervical cancer cell invasion, migration and epithelial-mesenchymal transition by suppressing the TGF-beta/smad pathway via binding to GREM1.
    Cancer Cell Int. 2019;19:147.
    PubMed     Text format     Abstract available

  10. GU X, Dong M, Liu Z, Mi Y, et al
    Elevated PD-L1 expression predicts poor survival outcomes in patients with cervical cancer.
    Cancer Cell Int. 2019;19:146.
    PubMed     Text format     Abstract available


    Cancer Manag Res

  11. YAN DD, Tang Q, Tu YQ, Chen JH, et al
    A comprehensive analysis of the factors of positive pelvic lymph nodes on survival of cervical cancer patients with 2018 FIGO stage IIIC1p.
    Cancer Manag Res. 2019;11:4223-4230.
    PubMed     Text format     Abstract available


    Clin Obstet Gynecol

  12. MCCUNE KC, Imborek KL
    Clinical Care of Lesbian and Bisexual Women for the Obstetrician Gynecologist.
    Clin Obstet Gynecol. 2018 Oct 3. doi: 10.1097/GRF.0000000000000399.
    PubMed     Text format     Abstract available


    Colloids Surf B Biointerfaces

  13. S R, M P
    Multi-functional core-shell Fe3O4@Au nanoparticles for cancer diagnosis and therapy.
    Colloids Surf B Biointerfaces. 2019;174:252-259.
    PubMed     Text format     Abstract available


    Cureus

  14. JAVAEED A, Shoukat S, Hina S, Hameed Z, et al
    Knowledge, Attitude, and Practices Related to Cervical Cancer Among Adult Women in Azad Kashmir: A Hospital-based Cross-sectional Study.
    Cureus. 2019;11:e4234.
    PubMed     Text format     Abstract available


    Eur Radiol

  15. SHEN WC, Chen SW, Wu KC, Hsieh TC, et al
    Prediction of local relapse and distant metastasis in patients with definitive chemoradiotherapy-treated cervical cancer by deep learning from [(18)F]-fluorodeoxyglucose positron emission tomography/computed tomography.
    Eur Radiol. 2019 May 27. pii: 10.1007/s00330-019-06265.
    PubMed     Text format     Abstract available


    Exp Cell Res

  16. ROJO-LEON V, Garcia C, Valencia C, Mendez MA, et al
    The E6/E7 oncogenes of human papilloma virus and estradiol regulate hedgehog signaling activity in a murine model of cervical cancer.
    Exp Cell Res. 2019 May 21. pii: S0014-4827(19)30265.
    PubMed     Text format     Abstract available


    Front Oncol

  17. CHATTERJEE K, Mukherjee S, Vanmanen J, Banerjee P, et al
    Dietary Polyphenols, Resveratrol and Pterostilbene Exhibit Antitumor Activity on an HPV E6-Positive Cervical Cancer Model: An in vitro and in vivo Analysis.
    Front Oncol. 2019;9:352.
    PubMed     Text format     Abstract available


    Gynecol Minim Invasive Ther

  18. LIM TYK, Lin KKM, Wong WL, Aggarwal IM, et al
    Surgical and Oncological Outcome of Total Laparoscopic Radical Hysterectomy versus Radical Abdominal Hysterectomy in Early Cervical Cancer in Singapore.
    Gynecol Minim Invasive Ther. 2019;8:53-58.
    PubMed     Text format     Abstract available

  19. ALAS QMDA, Lin CT
    Immunotherapy with Subcutaneous Injection of Immunomodulatory Agent (OK-432) Elicits Durable Response in Locally Advanced or Relapsed Cervical Cancer.
    Gynecol Minim Invasive Ther. 2019;8:80-82.
    PubMed     Text format     Abstract available


    Int J Cancer

  20. VAN LEEUWEN RW, Ostrbenk A, Poljak M, van der Zee AGJ, et al
    DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.
    Int J Cancer. 2019;144:746-754.
    PubMed     Text format     Abstract available


    Int J Clin Oncol

  21. KOBAYASHI Y, Tabata T, Omori M, Kondo E, et al
    A Japanese survey of malignant disease in pregnancy.
    Int J Clin Oncol. 2019;24:328-333.
    PubMed     Text format     Abstract available

  22. MATSUURA H, Arase S, Hori Y
    Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
    Int J Clin Oncol. 2019;24:306-312.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  23. OBERLIN AM, Pasipamire T, Chibwesha CJ
    Exploring women's preferences for HPV-based cervical cancer screening in South Africa.
    Int J Gynaecol Obstet. 2019 May 25. doi: 10.1002/ijgo.12869.
    PubMed     Text format     Abstract available


    Int J Gynecol Cancer

  24. VAN DER VELDEN J, Mom CH, van Lonkhuijzen L, Tjiong MY, et al
    Analysis of isolated loco-regional recurrence rate in intermediate risk early cervical cancer after a type C2 radical hysterectomy without adjuvant radiotherapy.
    Int J Gynecol Cancer. 2019 May 27. pii: ijgc-2019-000445.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  25. WAKATSUKI M, Kato S, Ohno T, Banu PA, et al
    Multi-institutional observational study of prophylactic extended-field concurrent chemoradiotherapy using weekly cisplatin for patients with pelvic node-positive cervical cancer in East and Southeast Asia.
    Int J Radiat Oncol Biol Phys. 2019 May 21. pii: S0360-3016(19)30737.
    PubMed     Text format     Abstract available

  26. MAHANTSHETTY U, Naga Ch P, Khadanga CR, Gudi S, et al
    A Prospective Comparison of Computed Tomography with Transrectal Ultrasonography Assistance and Magnetic Resonance Imaging-Based Target-Volume Definition During Image Guided Adaptive Brachytherapy for Cervical Cancers.
    Int J Radiat Oncol Biol Phys. 2018 Jun 7. pii: S0360-3016(18)30933.
    PubMed     Text format     Abstract available


    J BUON

  27. HUA F, Li CH, Gao YC, Li J, et al
    Molecular mechanism and role of NF-kappaB in the early diagnosis of cervical cancer.
    J BUON. 2019;24:720-728.
    PubMed     Text format     Abstract available


    J Cell Physiol

  28. SHAFABAKHSH R, Reiter RJ, Mirzaei H, Teymoordash SN, et al
    Melatonin: A new inhibitor agent for cervical cancer treatment.
    J Cell Physiol. 2019 May 27. doi: 10.1002/jcp.28865.
    PubMed     Text format     Abstract available


    J Contemp Brachytherapy

  29. MATSUKAWA H, Sasaki T, Hirayama R, Hirose TA, et al
    Assessment of the anatomical position of point B and the relationship between point B dose and the dose delivered to pelvic lymph nodes in CT-based high-dose-rate brachytherapy for uterine cervical cancer.
    J Contemp Brachytherapy. 2019;11:137-145.
    PubMed     Text format     Abstract available


    J Gynecol Oncol

  30. GUPTA S
    Adjuvant chemotherapy in locally advanced cervical cancer: the ceiling remains unbroken.
    J Gynecol Oncol. 2019;30:e97.
    PubMed     Text format    


    J Health Care Poor Underserved

  31. TSUI J, Llanos AA, Doose M, Rotter D, et al
    Determinants of Abnormal Cervical Cancer Screening Follow-Up And Invasive Cervical Cancer Among Uninsured and Underinsured Women in New Jersey.
    J Health Care Poor Underserved. 2019;30:680-701.
    PubMed     Text format     Abstract available


    J Low Genit Tract Dis

  32. PERKINS RB, Austin RM, Zhao C, Saslow D, et al
    What Role Should Cytology Play in Cervical Cancer Screening?
    J Low Genit Tract Dis. 2019 May 21. doi: 10.1097/LGT.0000000000000479.
    PubMed     Text format    


    J Med Econ

  33. MESSOUDI W, Elmahi T, Nejjari C, Tachfouti N, et al
    Cervical cancer prevention in Morocco: a model-based cost-effectiveness analysis.
    J Med Econ. 2019 May 28:1. doi: 10.1080/13696998.2019.1624556.
    PubMed     Text format     Abstract available


    J Obstet Gynaecol Can

  34. LEE F, Paszat LF, Sutradhar R
    Immigration and Adherence to Cervical Cancer Screening: A Provincewide Longitudinal Matched Cohort Study Using Multistate Transitional Models.
    J Obstet Gynaecol Can. 2019;41:813-823.
    PubMed     Text format     Abstract available


    J Obstet Gynaecol Res

  35. NAGASE S, Ohta T, Takahashi F, Enomoto T, et al
    Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patients report for 2015 and annual treatment report for 2010.
    J Obstet Gynaecol Res. 2019;45:289-298.
    PubMed     Text format     Abstract available


    JAMA

  36. SAWAYA GF, Smith-McCune K, Kuppermann M
    Cervical Cancer Screening: More Choices in 2019.
    JAMA. 2019;321:2018-2019.
    PubMed     Text format    


    Medicine (Baltimore)

  37. ZHAO H, He Y, Zhu LR, Wang JL, et al
    Effect of neoadjuvant chemotherapy followed by radical surgery for FIGO stage IB2/IIA2 cervical cancer: A multi-center retrospective clinical study.
    Medicine (Baltimore). 2019;98:e15604.
    PubMed     Text format     Abstract available

  38. MENG Y, Liu YL, Li K, Fu T, et al
    Prognostic value of long non-coding RNA breast cancer anti-estrogen resistance 4 in human cancers: A meta-analysis.
    Medicine (Baltimore). 2019;98:e15793.
    PubMed     Text format     Abstract available


    Mol Med

  39. LEE S, Ho JY, Liu JJ, Lee H, et al
    CKD-602, a topoisomerase I inhibitor, induces apoptosis and cell-cycle arrest and inhibits invasion in cervical cancer.
    Mol Med. 2019;25:23.
    PubMed     Text format     Abstract available


    Mol Med Rep

  40. CLEMENTE-SOTO AF, Salas-Vidal E, Milan-Pacheco C, Sanchez-Carranza JN, et al
    Quercetin induces G2 phase arrest and apoptosis with the activation of p53 in an E6 expressionindependent manner in HPVpositive human cervical cancerderived cells.
    Mol Med Rep. 2019;19:2097-2106.
    PubMed     Text format     Abstract available


    Obstet Gynecol

  41. RAO GG
    Surgical Volume and Survival in Cervical Cancer: Bigger Is Better.
    Obstet Gynecol. 2019;133:1084-1085.
    PubMed     Text format    

  42. MATSUO K, Shimada M, Yamaguchi S, Matoda M, et al
    Association of Radical Hysterectomy Surgical Volume and Survival for Early-Stage Cervical Cancer.
    Obstet Gynecol. 2019;133:1086-1098.
    PubMed     Text format     Abstract available


    Obstet Gynecol Sci

  43. AHN K, Kweon S, Kim DW, Lee H, et al
    Different expression of GSK3beta and pS9GSK3beta depending on phenotype of cervical cancer: possible association of GSK3beta with squamous cell carcinoma and pS9GSK3beta with adenocarcinoma.
    Obstet Gynecol Sci. 2019;62:157-165.
    PubMed     Text format     Abstract available


    PLoS One

  44. MCSHERRY LA, O'Leary E, Dombrowski SU, Francis JJ, et al
    Which primary care practitioners have poor human papillomavirus (HPV) knowledge? A step towards informing the development of professional education initiatives.
    PLoS One. 2018;13:e0208482.
    PubMed     Text format     Abstract available


    Prev Med

  45. PAPOUTSIS D
    An appraisal of the meta-analysis on the feasibility, acceptability, safety and efficacy of thermal ablation in the treatment of cervical cancer precursor lesions.
    Prev Med. 2019;123:341-342.
    PubMed     Text format    


    Radiology

  46. LEE SI, Atri M
    2018 FIGO Staging System for Uterine Cervical Cancer: Enter Cross-Sectional Imaging.
    Radiology. 2019 May 28:190088. doi: 10.1148/radiol.2019190088.
    PubMed     Text format     Abstract available


    Redox Biol

  47. WANG M, Xue Y, Shen L, Qin P, et al
    Inhibition of SGK1 confers vulnerability to redox dysregulation in cervical cancer.
    Redox Biol. 2019;24:101225.
    PubMed     Text format     Abstract available


    Sci Rep

  48. CARVALHO J, Paiva A, Cabral Campello MP, Paulo A, et al
    Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells.
    Sci Rep. 2019;9:7945.
    PubMed     Text format     Abstract available


    Support Care Cancer

  49. MAGUIRE PJ, Sobota A, Mulholland D, Ryan JM, et al
    Incidence, management, and sequelae of ureteric obstruction in women with cervical cancer.
    Support Care Cancer. 2019 May 25. pii: 10.1007/s00520-019-04851.
    PubMed     Text format     Abstract available


    Surg Case Rep

  50. YAMAZAKI H, Nakamura T, Otsuki Y, Tuchiya M, et al
    Sudden fatal bleeding from a uretero-arterial fistula combined with pre-existing uretero-colic and uretero-vaginal fistulas 7 years after a cervical cancer surgery: a case report.
    Surg Case Rep. 2019;5:85.
    PubMed     Text format     Abstract available


    Taiwan J Obstet Gynecol

  51. WANG W, Liu X, Meng Q, Zhang F, et al
    Comparisons of survivals and toxicities between young and elderly patients with cervical cancer treated with definitive radiotherapy or concurrent chemoradiotherapy.
    Taiwan J Obstet Gynecol. 2019;58:364-369.
    PubMed     Text format     Abstract available

  52. VAHEDPOOR Z, Behrashi M, Khamehchian T, Abedzadeh-Kalahroudi M, et al
    Comparison of the diagnostic value of the visual inspection with acetic acid (VIA) and Pap smear in cervical cancer screening.
    Taiwan J Obstet Gynecol. 2019;58:345-348.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: